Tumor – see the opportunity

In tumors, the bridging molecules are usually missing.
That means that the cell loses an important component for
its networking with the environment. An activated oncogene
and an inactivated suppressor gene can permanently
stimulate growth.
The objective of the research is to make tumor treatment
that is currently very poor more specific and targeted.
TREATING THE TUMOR PRIMARILY MEANS
INFLUENCING THE CELL‘S ENVIRONMENT
Because no tumor is alike, neither in the same organ nor
past organ boundaries, it can be concluded that targeted
therapeutic approaches are complex and require a casespecific
approach.
Here is an example from experimental research on how
the appearance of the cell and thus its behavior can be
changed by changing the cell‘s environment:
With certain cell growth factors (colony-stimulating factors),
tumor cells can be reprogrammed in such a way
so that they re-integrate into the tissue network with its
control mechanisms, even if they do remain genetically
changed. This result isn‘t actually surprising after what
was said about the significance of the environment for the
emergence of a tumor.
THE BEST TUMOR THERAPY IS PREVENTION
Because most tumors develop slowly over decades, prevention
should stand in first place today. By prevention,
we mean influencing the environment of the genetically
altered cell. Prevention comprises healthy and good quality
food. Eating is the most important environment modulator,
closely followed by regular exercise, i.e. sport, because
physical exercise activates the immune system and
suppresses inflammatory processes that are smoldering in
the body. It is also very important to not eat too much, i.e.
restrict calories.
Biestmilch belongs to the food plan (it is a foodstuff). It is
a kind of immune serum, a substance that is able to calm
down chronic inflammatory tissue.
BIESTMILCH CAN MODULATE
THE INFLAMMATORY ENVIRONMENT
OF THE TUMOR
The inflammatory response should actually contribute
towards removing the tumor cells. However, in the case
of humans with tumors, the inflammatory response is unproductive.
Inflammatory and anti-inflammatory processes
are no longer in balance but have displaced towards the
chronic inflammation. It is typical for the environment of
the tumor for receptors to become insensitive meaning no
effective antitumor response is generated.
Today, the therapeutic challenge principally lies in normalizing
the deregulated inflammatory network in such
a way that the result is a regular inflammatory response.
Thanks to its diversity, Biestmilch as one of the very few
substances available has this potential. Furthermore, it can
stabilize the immune system for chemotherapy to such an
extent that subsequent metastasizing can be influenced.
HOW TO TAKE BIESTMILCH:
You should take Biestmilch every day. Make it part of your
food plan. You don‘t interrupt the intake.
Take 900 mg every day. If you are taking Biestmilch as
preparation for chemotherapy or in addition to that, increase
the amount to 3 x 900 mg every day. After chemotherapy
reduce step by step to 900 mg or 600 mg. In the
case of a repeat chemo-cycle, please increase the dosage
again to 3 x 900 mg.
8
BIESTMILCH
Tumor – see the opportunity